UroGen Pharma (URGN) Net Equity Issued and Repurchased (2017 - 2026)
UroGen Pharma (URGN) posted Net Equity Issued and Repurchased of $887,000 for Q2 2026, up 198.7% from $297,000 a year earlier and up 395.5% from the prior quarter.
Powered by 
Analysis
UroGen Pharma (URGN) Net Equity Issued and Repurchased (2017 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, Net Equity Issued and Repurchased at UroGen Pharma was $40.54 million, up 164.4% year-over-year; for FY2025, it was $39.8 million, down 73.7% from FY2024.
- Annual Net Equity Issued and Repurchased shows a five-year compound annual growth rate of 20.2% (FY2020 to FY2025).
- In prior years, UroGen Pharma's Net Equity Issued and Repurchased was $151.17 million in FY2024 (+124.4%), $67.36 million in FY2023, $1.51 million in FY2022 and $61,000 in FY2021 (-99.6%).
- Quarterly Net Equity Issued and Repurchased has run from a low of $3,000 in Q3 2021 to a high of $81.51 million in Q2 2024 over five years.
- On a year-over-year basis, Net Equity Issued and Repurchased increased in two of the last six quarters, with growth averaging 61.5%.
- The strongest year-over-year quarter for Net Equity Issued and Repurchased in the past five years was Q2 2023, with growth of 793.8%; the weakest was Q1 2025, with a decline of 99.9%.
- According to Business Quant data, Net Equity Issued and Repurchased for the three prior quarters was $179,000 (Q1 2026), $31.83 million (Q4 2025) and $7.64 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,082.65 Bn | 1,051.23 Bn | 19.71 Bn | - |
| 2 | Johnson & Johnson | 623.68 Bn | 542.21 Bn | 17.26 Bn | - |
| 3 | AbbVie | 459.43 Bn | 432.59 Bn | 12.70 Bn | - |
| 4 | Merck | 354.80 Bn | 309.23 Bn | 12.21 Bn | 43.00 Mn |
| 5 | Novartis Ag | 269.16 Bn | 225.03 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 244.40 Bn | 217.97 Bn | 12.86 Bn | 6.00 Mn |
| 7 | Amgen | 220.17 Bn | 175.57 Bn | 7.24 Bn | - |
| 8 | Gilead Sciences | 183.05 Bn | 157.16 Bn | 6.22 Bn | 9.00 Mn |
| 9 | Pfizer | 160.27 Bn | 107.22 Bn | 10.94 Bn | - |
| 10 | UroGen Pharma | 1.98 Bn | 1.49 Bn | 65.88 Mn | 887,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 887,000.00 |
| Mar 31, 2026 | 179,000.00 |
| Dec 31, 2025 | 31.83 Mn |
| Sep 30, 2025 | 7.64 Mn |
| Jun 30, 2025 | 297,000.00 |
| Mar 31, 2025 | 30,000.00 |
| Sep 30, 2024 | 15.00 Mn |
| Jun 30, 2024 | 81.51 Mn |
| Mar 31, 2024 | 54.66 Mn |
| Sep 30, 2023 | 66.54 Mn |
| Jun 30, 2023 | 143,000.00 |
| Mar 31, 2023 | 671,000.00 |
| Dec 31, 2022 | 378,000.00 |
| Sep 30, 2022 | 1.12 Mn |
| Jun 30, 2022 | 16,000.00 |
| Sep 30, 2021 | 3,000.00 |
| Jun 30, 2021 | 54,000.00 |
| Mar 31, 2021 | 4,000.00 |
| Sep 30, 2020 | -32,000.00 |
| Jun 30, 2020 | 15.59 Mn |
API Access
UroGen Pharma Net Equity Issued and Repurchased API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=URGN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "net-equity-issued-and-repurchased", "ticker": "URGN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=URGN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();